Congress Looks to Move BIOSECURE Act

Key Takeaways

• A bill to limit US exposure to Chinese biotech firms has been introduced in the House and Senate.
• BIOSECURE would cast a wide net, including by prohibiting the federal government from entering into contracts with US companies that do business with designated Chinese biotech firms.
• The bill could find itself in the annual defense package as lawmakers negotiate a path forward.